Duke Clinical Research Institute
73
9
11
43
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
16.4%
12 terminated/withdrawn out of 73 trials
78.2%
-8.3% vs industry average
29%
21 trials in Phase 3/4
77%
33 of 43 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (73)
Home-Based Cardiac Rehabilitation Using a Novel Mobile Health Exercise Regimen Following Transcatheter Heart Valve Interventions
Role: collaborator
CIED Infection Quality Initiative Demonstration Project
Role: collaborator
A Study of Buntanetap in Participants With PD
Role: collaborator
COVID-19 Quick Start - Test and Treat in Africa
Role: collaborator
COMPARE - Pediatric Inflammatory Bowel Disease (PIBD)
Role: collaborator
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Role: collaborator
Synchronized Diaphragmatic Stimulation in Symptomatic Heart Failure
Role: collaborator
Comparing Optimized Models of Primary And Specialist Services for Palliative Care
Role: collaborator
Outcomes Database to prospectivelY aSSEss the Changing TherapY Landscape in Renal Cell Carcinoma
Role: collaborator
PK/PD of Digoxin in Infants With SVHD
Role: collaborator
The PLATFORM Study: Prospective LongitudinAl Trial of FFRct: Outcome and Resource IMpacts)
Role: collaborator
Healthy Living BEYOND Weight Study
Role: collaborator
Comparing Optimized Models of Primary And Specialist Services for Palliative Care: Pilot Feasibility Trial
Role: collaborator
Study to Assess the Safety of Amantadine Hydrochloride (HCl) Intravenous (IV) Solution (MR-301) in Patients With Severe Traumatic Brain Injury (TBI).
Role: collaborator
Defining the Safety and Efficacy of POSterIor Tibial NeRve StimulatiON in Children
Role: collaborator
IMplementation of an RCT to imProve Treatment With Oral AntiCoagulanTs in Patients With Atrial Fibrillation
Role: collaborator
Trial to Assess Chelation Therapy 2
Role: collaborator
Surveillance and Alert-based Multiparameter Monitoring to Reduce Worsening Heart Failure Events
Role: collaborator
Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)
Role: collaborator
Early Dronedarone Versus Usual Care to Improve Outcomes in Persons With Newly Diagnosed Atrial Fibrillation
Role: collaborator